<!DOCTYPE html>
<html lang="" xml:lang="">
<head>

  <meta charset="utf-8" />
  <meta http-equiv="X-UA-Compatible" content="IE=edge" />
  <title>15 Jejunostomy Feedings | GI Surgical Oncology</title>
  <meta name="description" content="Orientation Manual for GI Surgical Oncology Service" />
  <meta name="generator" content="bookdown 0.24 and GitBook 2.6.7" />

  <meta property="og:title" content="15 Jejunostomy Feedings | GI Surgical Oncology" />
  <meta property="og:type" content="book" />
  <meta property="og:url" content="https://github.com/gisurgonc/orientation" />
  
  <meta property="og:description" content="Orientation Manual for GI Surgical Oncology Service" />
  

  <meta name="twitter:card" content="summary" />
  <meta name="twitter:title" content="15 Jejunostomy Feedings | GI Surgical Oncology" />
  
  <meta name="twitter:description" content="Orientation Manual for GI Surgical Oncology Service" />
  




  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta name="apple-mobile-web-app-capable" content="yes" />
  <meta name="apple-mobile-web-app-status-bar-style" content="black" />
  <link rel="apple-touch-icon-precomposed" sizes="120x120" href="images/icon120.png" />
  <link rel="shortcut icon" href="images/favicon.io" type="image/x-icon" />
<link rel="prev" href="esophagectomy-ward.html"/>
<link rel="next" href="colorectal-cases---hillsquires.html"/>
<script src="libs/header-attrs-2.11/header-attrs.js"></script>
<script src="libs/jquery-3.5.1/jquery-3.5.1.min.js"></script>
<script src="https://cdn.jsdelivr.net/npm/fuse.js@6.4.6/dist/fuse.min.js"></script>
<link href="libs/gitbook-2.6.7/css/style.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-table.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-bookdown.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-highlight.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-search.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-fontsettings.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-clipboard.css" rel="stylesheet" />








<link href="libs/anchor-sections-1.0.1/anchor-sections.css" rel="stylesheet" />
<script src="libs/anchor-sections-1.0.1/anchor-sections.js"></script>



<style type="text/css">
/* Used with Pandoc 2.11+ new --citeproc when CSL is used */
div.csl-bib-body { }
div.csl-entry {
  clear: both;
}
.hanging div.csl-entry {
  margin-left:2em;
  text-indent:-2em;
}
div.csl-left-margin {
  min-width:2em;
  float:left;
}
div.csl-right-inline {
  margin-left:2em;
  padding-left:1em;
}
div.csl-indent {
  margin-left: 2em;
}
</style>

<link rel="stylesheet" href="style.css" type="text/css" />
</head>

<body>



  <div class="book without-animation with-summary font-size-2 font-family-1" data-basepath=".">

    <div class="book-summary">
      <nav role="navigation">

<ul class="summary">
<li>GI Surgical Oncology</li>

<li class="divider"></li>
<li><a href="index.html#Intro" id="toc-Intro"><span class="toc-section-number">1</span> Overview</a>
<ul>
<li><a href="index.html#absences" id="toc-absences"><span class="toc-section-number">1.1</span> Absences</a></li>
<li><a href="index.html#communication" id="toc-communication"><span class="toc-section-number">1.2</span> Communication</a></li>
<li><a href="index.html#medical-records" id="toc-medical-records"><span class="toc-section-number">1.3</span> Medical Records</a></li>
<li><a href="index.html#operative-logs" id="toc-operative-logs"><span class="toc-section-number">1.4</span> Operative Logs</a></li>
<li><a href="index.html#case-assignment" id="toc-case-assignment"><span class="toc-section-number">1.5</span> Case Assignment</a></li>
<li><a href="index.html#clinic" id="toc-clinic"><span class="toc-section-number">1.6</span> Clinic</a></li>
<li><a href="index.html#work-hours" id="toc-work-hours"><span class="toc-section-number">1.7</span> Work Hours</a></li>
</ul></li>
<li><a href="cmc-inpatient.html#cmc-inpatient" id="toc-cmc-inpatient"><span class="toc-section-number">2</span> CMC Inpatient</a>
<ul>
<li><a href="cmc-inpatient.html#admissions" id="toc-admissions"><span class="toc-section-number">2.1</span> Admissions</a></li>
<li><a href="cmc-inpatient.html#rounds" id="toc-rounds"><span class="toc-section-number">2.2</span> Rounds</a></li>
<li><a href="cmc-inpatient.html#resident-epic-teams" id="toc-resident-epic-teams"><span class="toc-section-number">2.3</span> Resident Epic teams:</a></li>
<li><a href="cmc-inpatient.html#consults" id="toc-consults"><span class="toc-section-number">2.4</span> Consults</a></li>
<li><a href="cmc-inpatient.html#postop-clinic-appt" id="toc-postop-clinic-appt"><span class="toc-section-number">2.5</span> Postop Clinic Appt</a></li>
<li><a href="cmc-inpatient.html#conferences" id="toc-conferences"><span class="toc-section-number">2.6</span> Conferences</a></li>
</ul></li>
<li><a href="pineville-inpatient.html#pineville-inpatient" id="toc-pineville-inpatient"><span class="toc-section-number">3</span> Pineville Inpatient</a>
<ul>
<li><a href="pineville-inpatient.html#rounds-1" id="toc-rounds-1"><span class="toc-section-number">3.1</span> Rounds</a></li>
<li><a href="pineville-inpatient.html#resident-epic-teams-1" id="toc-resident-epic-teams-1"><span class="toc-section-number">3.2</span> Resident Epic teams:</a></li>
<li><a href="pineville-inpatient.html#consults-1" id="toc-consults-1"><span class="toc-section-number">3.3</span> Consults</a></li>
<li><a href="pineville-inpatient.html#postop-clinic-appts" id="toc-postop-clinic-appts"><span class="toc-section-number">3.4</span> Postop Clinic Appts</a></li>
<li><a href="pineville-inpatient.html#conferences-1" id="toc-conferences-1"><span class="toc-section-number">3.5</span> Conferences</a></li>
</ul></li>
<li><a href="rounds-2.html#rounds-2" id="toc-rounds-2"><span class="toc-section-number">4</span> Rounds</a></li>
<li><a href="progress-notes.html#progress-notes" id="toc-progress-notes"><span class="toc-section-number">5</span> Progress Notes</a></li>
<li><a href="discharges.html#discharges" id="toc-discharges"><span class="toc-section-number">6</span> Discharges</a></li>
<li><a href="education.html#education" id="toc-education"><span class="toc-section-number">7</span> Education</a></li>
<li><a href="clinic-1.html#clinic-1" id="toc-clinic-1"><span class="toc-section-number">8</span> Clinic</a>
<ul>
<li><a href="clinic-1.html#salo-clinic" id="toc-salo-clinic"><span class="toc-section-number">8.1</span> Salo Clinic</a></li>
</ul></li>
<li><a href="mie_postop.html#mie_postop" id="toc-mie_postop"><span class="toc-section-number">9</span> Postop Care after Esophagectomy</a>
<ul>
<li><a href="mie_postop.html#weaning-tube-feeds-in-diabetics" id="toc-weaning-tube-feeds-in-diabetics"><span class="toc-section-number">9.1</span> Weaning Tube Feeds in Diabetics</a></li>
</ul></li>
<li><a href="#part-postoperative-care" id="toc-part-postoperative-care">(PART*) Postoperative Care</a></li>
<li><a href="colectomy.html#colectomy" id="toc-colectomy"><span class="toc-section-number">10</span> Colectomy</a></li>
<li><a href="lar-ileostomy.html#lar-ileostomy" id="toc-lar-ileostomy"><span class="toc-section-number">11</span> LAR + Ileostomy</a></li>
<li><a href="abdominoperineal-resection.html#abdominoperineal-resection" id="toc-abdominoperineal-resection"><span class="toc-section-number">12</span> Abdominoperineal Resection</a></li>
<li><a href="esophagectomy-postop.html#esophagectomy-postop" id="toc-esophagectomy-postop"><span class="toc-section-number">13</span> Esophagectomy Postop</a></li>
<li><a href="esophagectomy-ward.html#esophagectomy-ward" id="toc-esophagectomy-ward"><span class="toc-section-number">14</span> Esophagectomy Ward</a>
<ul>
<li><a href="esophagectomy-ward.html#anti-hypertensives" id="toc-anti-hypertensives"><span class="toc-section-number">14.1</span> Anti-Hypertensives</a></li>
<li><a href="esophagectomy-ward.html#chest-tubes" id="toc-chest-tubes"><span class="toc-section-number">14.2</span> Chest tubes</a></li>
<li><a href="esophagectomy-ward.html#gi-medicines" id="toc-gi-medicines"><span class="toc-section-number">14.3</span> GI Medicines</a></li>
<li><a href="esophagectomy-ward.html#leak_evaluation" id="toc-leak_evaluation"><span class="toc-section-number">14.4</span> Evaluation for leak</a>
<ul>
<li><a href="esophagectomy-ward.html#drain_amylase" id="toc-drain_amylase"><span class="toc-section-number">14.4.1</span> Drain Amylase</a></li>
<li><a href="esophagectomy-ward.html#ct_esophagram" id="toc-ct_esophagram"><span class="toc-section-number">14.4.2</span> CT esophagram</a></li>
</ul></li>
<li><a href="esophagectomy-ward.html#anastomotic-leak-treatment" id="toc-anastomotic-leak-treatment"><span class="toc-section-number">14.5</span> Anastomotic Leak Treatment</a></li>
</ul></li>
<li><a href="jejunostomy-feedings.html#jejunostomy-feedings" id="toc-jejunostomy-feedings"><span class="toc-section-number">15</span> Jejunostomy Feedings</a>
<ul>
<li><a href="jejunostomy-feedings.html#med-administration-via-j-tubes" id="toc-med-administration-via-j-tubes"><span class="toc-section-number">15.1</span> Med Administration via J-Tubes</a></li>
<li><a href="jejunostomy-feedings.html#occluded-jejunostomy-tubes" id="toc-occluded-jejunostomy-tubes"><span class="toc-section-number">15.2</span> Occluded Jejunostomy Tubes</a></li>
<li><a href="jejunostomy-feedings.html#jejunostomy_diabetes" id="toc-jejunostomy_diabetes"><span class="toc-section-number">15.3</span> Jejunostomy + Diabetes</a></li>
</ul></li>
<li><a href="#part-hill-or" id="toc-part-hill-or">(PART*) Hill OR</a></li>
<li><a href="colorectal-cases---hillsquires.html#colorectal-cases---hillsquires" id="toc-colorectal-cases---hillsquires"><span class="toc-section-number">16</span> Colorectal Cases - Hill/Squires</a></li>
<li><a href="#part-salo-or" id="toc-part-salo-or">(PART*) Salo OR</a></li>
<li><a href="cv_port_salo.html#cv_port_salo" id="toc-cv_port_salo"><span class="toc-section-number">17</span> CV Port (IJ)</a></li>
<li><a href="lap-jejunostomy.html#lap-jejunostomy" id="toc-lap-jejunostomy"><span class="toc-section-number">18</span> Lap Jejunostomy</a></li>
<li><a href="lap_gastrostomy_salo.html#lap_gastrostomy_salo" id="toc-lap_gastrostomy_salo"><span class="toc-section-number">19</span> Lap Gastrostomy</a></li>
<li><a href="esophagectomy-1-stage.html#esophagectomy-1-stage" id="toc-esophagectomy-1-stage"><span class="toc-section-number">20</span> Esophagectomy 1 Stage</a>
<ul>
<li><a href="esophagectomy-1-stage.html#indications" id="toc-indications"><span class="toc-section-number">20.1</span> Indications</a></li>
<li><a href="esophagectomy-1-stage.html#room-prep" id="toc-room-prep"><span class="toc-section-number">20.2</span> Room Prep</a>
<ul>
<li><a href="esophagectomy-1-stage.html#time-out" id="toc-time-out"><span class="toc-section-number">20.2.1</span> Time Out</a></li>
</ul></li>
<li><a href="esophagectomy-1-stage.html#gastric-mobilization" id="toc-gastric-mobilization"><span class="toc-section-number">20.3</span> Gastric Mobilization</a>
<ul>
<li><a href="esophagectomy-1-stage.html#distal-mobilization" id="toc-distal-mobilization"><span class="toc-section-number">20.3.1</span> Distal mobilization</a></li>
<li><a href="esophagectomy-1-stage.html#left-gastric-artery" id="toc-left-gastric-artery"><span class="toc-section-number">20.3.2</span> Left gastric artery</a></li>
<li><a href="esophagectomy-1-stage.html#mediastinal-dissection" id="toc-mediastinal-dissection"><span class="toc-section-number">20.3.3</span> Mediastinal dissection</a></li>
<li><a href="esophagectomy-1-stage.html#division-of-esophagus-four-phase" id="toc-division-of-esophagus-four-phase"><span class="toc-section-number">20.3.4</span> Division of Esophagus (Four-Phase)</a></li>
<li><a href="esophagectomy-1-stage.html#entry-into-right-chest" id="toc-entry-into-right-chest"><span class="toc-section-number">20.3.5</span> Entry into right chest</a></li>
</ul></li>
</ul></li>
<li><a href="#part-esophageal-cancer" id="toc-part-esophageal-cancer">(PART*) Esophageal Cancer</a></li>
<li><a href="EsoObjJB.html#EsoObjJB" id="toc-EsoObjJB"><span class="toc-section-number">21</span> EsoCa SCORE - JR</a></li>
<li><a href="EsoObjCR.html#EsoObjCR" id="toc-EsoObjCR"><span class="toc-section-number">22</span> EsoCa Objectives - Chief</a></li>
<li><a href="EsoIntro.html#EsoIntro" id="toc-EsoIntro"><span class="toc-section-number">23</span> Esophageal Overview</a></li>
<li><a href="staging.html#staging" id="toc-staging"><span class="toc-section-number">24</span> Staging</a></li>
<li><a href="superficial.html#superficial" id="toc-superficial"><span class="toc-section-number">25</span> Superficial EsoCa</a>
<ul>
<li><a href="superficial.html#emr" id="toc-emr"><span class="toc-section-number">25.1</span> Endscopic Mucosal Resection (EMR)</a></li>
</ul></li>
<li><a href="localized.html#localized" id="toc-localized"><span class="toc-section-number">26</span> Localized EsoCa</a>
<ul>
<li><a href="localized.html#t1b-tumors" id="toc-t1b-tumors"><span class="toc-section-number">26.1</span> T1b Tumors</a></li>
<li><a href="localized.html#t2n0-tumors" id="toc-t2n0-tumors"><span class="toc-section-number">26.2</span> T2N0 Tumors</a></li>
<li><a href="localized.html#staging-of-t2n0-tumors" id="toc-staging-of-t2n0-tumors"><span class="toc-section-number">26.3</span> Staging of T2N0 Tumors</a></li>
</ul></li>
<li><a href="locally_advanced.html#locally_advanced" id="toc-locally_advanced"><span class="toc-section-number">27</span> Locally Advanced EsoCa</a>
<ul>
<li><a href="locally_advanced.html#trimodality" id="toc-trimodality"><span class="toc-section-number">27.1</span> Trimodality Therapy</a>
<ul>
<li><a href="locally_advanced.html#neoadjuvant-chemort-for-scca" id="toc-neoadjuvant-chemort-for-scca"><span class="toc-section-number">27.1.1</span> Neoadjuvant chemoRT for SCCA</a></li>
<li><a href="locally_advanced.html#neoadjuvant-chemotheraphy-followed-by-surgery" id="toc-neoadjuvant-chemotheraphy-followed-by-surgery"><span class="toc-section-number">27.1.2</span> Neoadjuvant chemotheraphy followed by surgery</a></li>
</ul></li>
<li><a href="locally_advanced.html#ge-junction" id="toc-ge-junction"><span class="toc-section-number">27.2</span> GE Junction</a></li>
<li><a href="locally_advanced.html#induction-chemotherapy-followed-by-chemort" id="toc-induction-chemotherapy-followed-by-chemort"><span class="toc-section-number">27.3</span> Induction chemotherapy followed by chemoRT</a></li>
<li><a href="locally_advanced.html#postoperative-chemoradiation" id="toc-postoperative-chemoradiation"><span class="toc-section-number">27.4</span> Postoperative chemoradiation</a></li>
</ul></li>
<li><a href="eso_dcrt.html#eso_dcrt" id="toc-eso_dcrt"><span class="toc-section-number">28</span> Chemoradiation</a>
<ul>
<li><a href="eso_dcrt.html#phase-ii-studies" id="toc-phase-ii-studies"><span class="toc-section-number">28.1</span> Phase II Studies</a></li>
<li><a href="eso_dcrt.html#chemort-vs-trimodality-therapy" id="toc-chemort-vs-trimodality-therapy"><span class="toc-section-number">28.2</span> ChemoRT vs Trimodality therapy</a></li>
</ul></li>
<li><a href="radiation.html#radiation" id="toc-radiation"><span class="toc-section-number">29</span> Radiation</a></li>
<li><a href="esophagectomy.html#esophagectomy" id="toc-esophagectomy"><span class="toc-section-number">30</span> Esophagectomy</a>
<ul>
<li><a href="esophagectomy.html#ge-junction-adenocarcinoma" id="toc-ge-junction-adenocarcinoma"><span class="toc-section-number">30.0.1</span> GE Junction Adenocarcinoma</a></li>
<li><a href="esophagectomy.html#preoperative-evaluation" id="toc-preoperative-evaluation"><span class="toc-section-number">30.0.2</span> Preoperative Evaluation</a></li>
<li><a href="esophagectomy.html#minimally-invasive-esophagectomy" id="toc-minimally-invasive-esophagectomy"><span class="toc-section-number">30.1</span> Minimally-invasive Esophagectomy</a></li>
<li><a href="esophagectomy.html#early-recovery-pathways" id="toc-early-recovery-pathways"><span class="toc-section-number">30.2</span> Early Recovery Pathways</a></li>
<li><a href="esophagectomy.html#salvage-esophagectomy" id="toc-salvage-esophagectomy"><span class="toc-section-number">30.3</span> Salvage esophagectomy</a></li>
</ul></li>
<li><a href="eso_metastatic.html#eso_metastatic" id="toc-eso_metastatic"><span class="toc-section-number">31</span> Metastatic EsoCa</a>
<ul>
<li><a href="eso_metastatic.html#palliative-radiation" id="toc-palliative-radiation"><span class="toc-section-number">31.1</span> Palliative radiation</a></li>
<li><a href="eso_metastatic.html#chemoradiation-vs-chemotherapy-in-stage-iv" id="toc-chemoradiation-vs-chemotherapy-in-stage-iv"><span class="toc-section-number">31.2</span> Chemoradiation vs chemotherapy in Stage IV</a></li>
<li><a href="eso_metastatic.html#stents-for-malignant-disease" id="toc-stents-for-malignant-disease"><span class="toc-section-number">31.3</span> Stents for malignant disease</a></li>
</ul></li>
<li><a href="eso_survivorship.html#eso_survivorship" id="toc-eso_survivorship"><span class="toc-section-number">32</span> Survivorship</a>
<ul>
<li><a href="eso_survivorship.html#nutritional-consequences-of-esophagectomy" id="toc-nutritional-consequences-of-esophagectomy"><span class="toc-section-number">32.1</span> Nutritional consequences of esophagectomy</a>
<ul>
<li><a href="eso_survivorship.html#vitamin-d-deficiency" id="toc-vitamin-d-deficiency"><span class="toc-section-number">32.1.1</span> Vitamin D deficiency</a></li>
</ul></li>
<li><a href="eso_survivorship.html#cardiac-toxicity-of-radiation" id="toc-cardiac-toxicity-of-radiation"><span class="toc-section-number">32.2</span> Cardiac toxicity of radiation</a></li>
<li><a href="eso_survivorship.html#eso_surveillance" id="toc-eso_surveillance"><span class="toc-section-number">32.3</span> Surveillance</a></li>
</ul></li>
<li><a href="#part-gastric-cancer" id="toc-part-gastric-cancer">(PART*) Gastric Cancer</a></li>
<li><a href="gastric-ca-score.html#gastric-ca-score" id="toc-gastric-ca-score"><span class="toc-section-number">33</span> Gastric Ca SCORE</a></li>
<li><a href="gast_superficial.html#gast_superficial" id="toc-gast_superficial"><span class="toc-section-number">34</span> Superficial Gastric</a></li>
<li><a href="locally-advanced-gastric.html#locally-advanced-gastric" id="toc-locally-advanced-gastric"><span class="toc-section-number">35</span> Locally-Advanced Gastric</a>
<ul>
<li><a href="locally-advanced-gastric.html#preoperative-chemotherapy" id="toc-preoperative-chemotherapy"><span class="toc-section-number">35.1</span> Preoperative Chemotherapy</a></li>
<li><a href="locally-advanced-gastric.html#postoperative-chemotherapy" id="toc-postoperative-chemotherapy"><span class="toc-section-number">35.2</span> Postoperative chemotherapy</a></li>
<li><a href="locally-advanced-gastric.html#postoperative-chemoradiation-1" id="toc-postoperative-chemoradiation-1"><span class="toc-section-number">35.3</span> Postoperative chemoradiation</a></li>
<li><a href="locally-advanced-gastric.html#preoperative-chemoradiation" id="toc-preoperative-chemoradiation"><span class="toc-section-number">35.4</span> Preoperative chemoradiation</a></li>
</ul></li>
<li><a href="hereditary-diffuse-gastric-cancer.html#hereditary-diffuse-gastric-cancer" id="toc-hereditary-diffuse-gastric-cancer"><span class="toc-section-number">36</span> Hereditary Diffuse Gastric Cancer</a></li>
<li><a href="gastrectomy.html#gastrectomy" id="toc-gastrectomy"><span class="toc-section-number">37</span> Gastrectomy</a>
<ul>
<li><a href="gastrectomy.html#proximal-gastrectomy" id="toc-proximal-gastrectomy"><span class="toc-section-number">37.1</span> Proximal gastrectomy</a></li>
</ul></li>
<li><a href="#part-colon-cancer" id="toc-part-colon-cancer">(PART*) Colon Cancer</a></li>
<li><a href="ColonObjCR.html#ColonObjCR" id="toc-ColonObjCR"><span class="toc-section-number">38</span> ColonCa SCORE</a></li>
<li><a href="PColectomyObj.html#PColectomyObj" id="toc-PColectomyObj"><span class="toc-section-number">39</span> Partial Colectomy SCORE</a></li>
<li><a href="ColostomyObj.html#ColostomyObj" id="toc-ColostomyObj"><span class="toc-section-number">40</span> Colostomy SCORE</a></li>
<li><a href="TColectomyObj.html#TColectomyObj" id="toc-TColectomyObj"><span class="toc-section-number">41</span> Total Colectomy SCORE</a></li>
<li><a href="stage-iv-colon-cancer.html#stage-iv-colon-cancer" id="toc-stage-iv-colon-cancer"><span class="toc-section-number">42</span> Stage IV Colon Cancer</a>
<ul>
<li><a href="stage-iv-colon-cancer.html#carcinomatosis" id="toc-carcinomatosis"><span class="toc-section-number">42.1</span> Carcinomatosis</a></li>
<li><a href="stage-iv-colon-cancer.html#colon-resection-in-stage-iv-colon-cancer" id="toc-colon-resection-in-stage-iv-colon-cancer"><span class="toc-section-number">42.2</span> Colon resection in stage IV colon cancer</a></li>
<li><a href="stage-iv-colon-cancer.html#immunotherapy-for-dmmr-msi-high" id="toc-immunotherapy-for-dmmr-msi-high"><span class="toc-section-number">42.3</span> Immunotherapy for dMMR (MSI high)</a></li>
</ul></li>
<li><a href="colectomy-1.html#colectomy-1" id="toc-colectomy-1"><span class="toc-section-number">43</span> Colectomy</a>
<ul>
<li><a href="colectomy-1.html#extended-node-dissection" id="toc-extended-node-dissection"><span class="toc-section-number">43.1</span> Extended Node dissection</a></li>
</ul></li>
<li><a href="chemotherapy.html#chemotherapy" id="toc-chemotherapy"><span class="toc-section-number">44</span> Chemotherapy</a>
<ul>
<li><a href="chemotherapy.html#neoadjuvant-chemotherapy" id="toc-neoadjuvant-chemotherapy"><span class="toc-section-number">44.1</span> Neoadjuvant Chemotherapy</a></li>
</ul></li>
<li><a href="#part-rectal-cancer" id="toc-part-rectal-cancer">(PART*) Rectal Cancer</a></li>
<li><a href="rectalca-score.html#rectalca-score" id="toc-rectalca-score"><span class="toc-section-number">45</span> RectalCa SCORE</a>
<ul>
<li><a href="rectalca-score.html#anatomy" id="toc-anatomy"><span class="toc-section-number">45.1</span> Anatomy</a></li>
<li><a href="rectalca-score.html#presentation" id="toc-presentation"><span class="toc-section-number">45.2</span> Presentation</a></li>
<li><a href="rectalca-score.html#operative-treatment" id="toc-operative-treatment"><span class="toc-section-number">45.3</span> Operative Treatment</a>
<ul>
<li><a href="rectalca-score.html#total-mesorectal-excision" id="toc-total-mesorectal-excision"><span class="toc-section-number">45.3.1</span> Total mesorectal excision</a></li>
<li><a href="rectalca-score.html#transanal-excision" id="toc-transanal-excision"><span class="toc-section-number">45.3.2</span> Transanal excision</a></li>
<li><a href="rectalca-score.html#isolated-liver-metastasis" id="toc-isolated-liver-metastasis"><span class="toc-section-number">45.3.3</span> Isolated liver metastasis</a></li>
</ul></li>
<li><a href="rectalca-score.html#adjuvant-therapy" id="toc-adjuvant-therapy"><span class="toc-section-number">45.4</span> Adjuvant therapy</a></li>
</ul></li>
<li><a href="objectives---aprexent.html#objectives---aprexent" id="toc-objectives---aprexent"><span class="toc-section-number">46</span> Objectives - APR/Exent</a>
<ul>
<li><a href="objectives---aprexent.html#indications-1" id="toc-indications-1"><span class="toc-section-number">46.1</span> Indications</a></li>
<li><a href="objectives---aprexent.html#operative-anatomy" id="toc-operative-anatomy"><span class="toc-section-number">46.2</span> Operative Anatomy</a></li>
<li><a href="objectives---aprexent.html#preop-prep" id="toc-preop-prep"><span class="toc-section-number">46.3</span> Preop Prep</a></li>
<li><a href="objectives---aprexent.html#key-steps" id="toc-key-steps"><span class="toc-section-number">46.4</span> Key Steps</a></li>
<li><a href="objectives---aprexent.html#intraop-decisions" id="toc-intraop-decisions"><span class="toc-section-number">46.5</span> Intraop Decisions</a></li>
<li><a href="objectives---aprexent.html#complications" id="toc-complications"><span class="toc-section-number">46.6</span> Complications</a></li>
</ul></li>
<li><a href="rectal-cancer-staging.html#rectal-cancer-staging" id="toc-rectal-cancer-staging"><span class="toc-section-number">47</span> Rectal Cancer Staging</a>
<ul>
<li><a href="rectal-cancer-staging.html#mri-staging" id="toc-mri-staging"><span class="toc-section-number">47.1</span> MRI staging</a></li>
</ul></li>
<li><a href="rectal-cancer-surgery.html#rectal-cancer-surgery" id="toc-rectal-cancer-surgery"><span class="toc-section-number">48</span> Rectal Cancer Surgery</a></li>
<li><a href="rectal-adjuvant-therapy.html#rectal-adjuvant-therapy" id="toc-rectal-adjuvant-therapy"><span class="toc-section-number">49</span> Rectal Adjuvant Therapy</a>
<ul>
<li><a href="rectal-adjuvant-therapy.html#short-course-preoperative-therapy" id="toc-short-course-preoperative-therapy"><span class="toc-section-number">49.0.1</span> Short-course preoperative therapy</a></li>
<li><a href="rectal-adjuvant-therapy.html#total-neoadjuvant-therapy" id="toc-total-neoadjuvant-therapy"><span class="toc-section-number">49.0.2</span> Total Neoadjuvant therapy</a></li>
<li><a href="rectal-adjuvant-therapy.html#neoadjuvant-immunotherapy-msi-high" id="toc-neoadjuvant-immunotherapy-msi-high"><span class="toc-section-number">49.1</span> Neoadjuvant immunotherapy (MSI high)</a></li>
<li><a href="rectal-adjuvant-therapy.html#non-operative-management-of-rectal-cancer" id="toc-non-operative-management-of-rectal-cancer"><span class="toc-section-number">49.2</span> Non-operative management of Rectal Cancer</a></li>
</ul></li>
<li><a href="#part-sarcoma" id="toc-part-sarcoma">(PART*) Sarcoma</a></li>
<li><a href="soft-tissue-sarcomas.html#soft-tissue-sarcomas" id="toc-soft-tissue-sarcomas"><span class="toc-section-number">50</span> Soft Tissue Sarcomas</a>
<ul>
<li><a href="soft-tissue-sarcomas.html#desmoid-tumors" id="toc-desmoid-tumors"><span class="toc-section-number">50.1</span> Desmoid Tumors</a></li>
<li><a href="soft-tissue-sarcomas.html#retroperitoneal" id="toc-retroperitoneal"><span class="toc-section-number">50.2</span> Retroperitoneal</a></li>
<li><a href="soft-tissue-sarcomas.html#peritoneal-mesothelioma" id="toc-peritoneal-mesothelioma"><span class="toc-section-number">50.3</span> Peritoneal mesothelioma</a></li>
</ul></li>
<li><a href="references.html#references" id="toc-references">References</a></li>
<li class="divider"></li>
<li><a href="mailto:jonathan.salo@atriumhealth.org">Feedback and Updates</a></li>

</ul>

      </nav>
    </div>

    <div class="book-body">
      <div class="body-inner">
        <div class="book-header" role="navigation">
          <h1>
            <i class="fa fa-circle-o-notch fa-spin"></i><a href="./">GI Surgical Oncology</a>
          </h1>
        </div>

        <div class="page-wrapper" tabindex="-1" role="main">
          <div class="page-inner">

            <section class="normal" id="section-">
<div id="jejunostomy-feedings" class="section level1" number="15">
<h1><span class="header-section-number">15</span> Jejunostomy Feedings</h1>
<p>Due to the osmotic load, jejunostomy feedings are given via enteral (Kangaroo) pump rather than bolus feeding. Feedings are generally begun as continuous (around-the-clock) and are then transitioned to nocturnal (generally 6pm to 10am) prior to discharge.</p>
<p>Jejunostomy feedings carry a small but significant risk (~1%) of small bowel necrosis, as evidenced by the findings of pneumatosis on CT scan and in some cases small bowel necrosis and perforation. The existing literature would suggest that the early symptoms associated with small bowel necrosis are abdominal distension. As a result, patients on jejunostomy tube feeding need to be carefully monitored for distension, and tube feeds held if distension develops.<span class="citation">(<a href="#ref-taylor34" role="doc-biblioref">Taylor et al. 2014</a>)</span> Tube feeds are generally started at 30mL/hour in the immediate postoperative patients. In patients who are awake and in whom it is possible to determine whether or not there are issues of tube feed intolerance, the rate of tube feedings is increased 10mL/hour every 12 hours to a goal of 60mL/hour for women and 75mL/hour for men. In patients who are intubated/sedated, the advancement of tube feeds is individualized, and decisions are made on a daily basis on rounds.</p>
<p>For patients who receive tube feedings preoperatively, the same formula is generally used after surgery.</p>
<p>For patients with BMI less than 35, Osmolite 1.5 is used as a starting formula. If Osmolite is not tolerated due to diarrhea, Vital 1.5 can be used. For patients with BMI greater than 35, Promote is used as a starting formula, as it contains a lower amount of carbohydrates then Osmolite 1.5. Patients who are intolerant to Promote can be switched to Vital High Protein.</p>
<p>Patients less than 150 pounds receive 4 cans of tube feedings, administered at 60mL/hour x 16 hours (6pm to 10am). Patients greater than 150 pounds receive 5 cans of tube feedings, administered at 75mL/hour x 16 hours (6pm to 10am). Patients with BMI &gt;35 receive 5 cans of Promote (or Vital High Protein).</p>
<p>Glucerna is formulated with carbohydrates with low glycemic index, which is particularly helpful for bolus feeding (via gastrostomy) or patients who are eating. Glycemic index is less important in patients on continuous tube feeds (eg via jejunostomy). In addition, the high fiber context of Glucerna may make this formula more prone to causing clogging of jejunostomy tubes.
Free Water Flushes</p>
<p>Once patients are transferred to the ward, free water via jejunostomy should be ordered as 240mL via jejunostomy qid. This is entered under Flush Enteral Tube for Free Water Requirements.
Diarrhea with Jejunostomy Feedings</p>
<p>Patients who experience diarrhea during jejunostomy administration (especially diarrhea at night) will need this addressed. Several steps</p>
<ul>
<li>Send stool for C Diff</li>
<li>Consider changing tube feedings to a more easily digestible formula. Patients on Osmolite 1.5 can be changed to Vital 1.5. Patients on Vital 1.5 can be changed to Vivonex. Patients on Promote can be changed to Vital High Protein</li>
<li>Stop tube feedings for 2-4 hours to allow diarrhea to resolve</li>
<li>restart tube feeds at a lower rate (eg 20mL/hour lower than the prior rate).</li>
<li>Bannatrol can be given to patients taking an oral diet. Bannatrol is NOT given via jejunostomy tube to avoid clogging.</li>
<li>Lomotil is generally used as a last resort.</li>
</ul>
<div id="med-administration-via-j-tubes" class="section level2" number="15.1">
<h2><span class="header-section-number">15.1</span> Med Administration via J-Tubes</h2>
<p>Patients who have difficulty with dysphagia or complete esophageal obstruction will need to have their medicines administered via jejunostomy tube. The process of designing a medicine regimen which can safely be administered via enteral tube can be a challenge and may require a consultation with the hospital pharmacist. One the other hand, the financial consequences of a clogged feeding tube are substantial. <strong>Flomax is never given via jejunostomy tubes due to risk of clogging</strong>.</p>
<p>Several common medicines are available in liquid form:</p>
<ul>
<li>Acetaminophen (pediatric formulation)</li>
<li>Gabapentin</li>
<li>Oxycodone</li>
<li>Hydrocodone + acetaminophen</li>
<li>Reglan</li>
</ul>
</div>
<div id="occluded-jejunostomy-tubes" class="section level2" number="15.2">
<h2><span class="header-section-number">15.2</span> Occluded Jejunostomy Tubes</h2>
<p>Jejunostomy tubes which are refractory to the usual non-invasive means (warm water, Coca-Cola) will need to be changed over a wire in Interventional Radiology.</p>

</div>
<div id="jejunostomy_diabetes" class="section level2" number="15.3">
<h2><span class="header-section-number">15.3</span> Jejunostomy + Diabetes</h2>
<p><strong>Inpt – Jejunostomy ~ Diabetes</strong></p>
<p>Patients on tube feeds are typically started on continuous (around-the-clock) tube feedings, and subsequently changed to a nocturnal regimen (typically 6pm to 10am). The diabetic management for these patients differs depending upon their tube feeding regimen:</p>
<p><strong>Diabetics on Continuous Tube Feeds.</strong></p>
<p>Non-insulin diabetic patients are generally initially given Osmolite 1.5 as it provides higher caloric density and does not contain fiber, which tends to clog the feeding tubes. Diabetic patients requiring insulin can be initially trialed on Osmolite 1.5 but are changed to Promote or Glucerna 1.5 if their blood sugars prove difficult to control (as evidence by either the need for EndoTool or requiring a q6 hour regimen of insulin N + insulin R).</p>
<p>Diabetic patients who need insulin while receiving tube feedings are typically treated initially with continuous tube feedings and around-the-clock insulin. Patients with large insulin requirements may need hourly intravenous insulin (with dosages calculated via EndoTool). Once their insulin requirements are stabilized, they are transitioned to a q6 hour regimen consisting of N and R insulin, typically twice as many units of N insulin as R (for instance, 6Units of N + 3 Units of R insulin every six hours). Patients who require EndoTool or a q6hr regimen need an endocrinology consultation with Dr Kelli Dunn to assist in diabetic management.</p>
<p><strong>Diabetics on Nocturnal Tube Feeds</strong></p>
<p>Most patients are transitioned from continuous tube feeds to nocturnal prior to discharge. Diabetic patients on nocturnal tube feedings typically receive tube feeding from 6pm to 10am and receive insulin at initiation of tube feeds (6pm) and again at 6 hours later (midnight). A typical regimen might be 18U of 70/30 at 1800 and 18U of 70/30 at MN. An alternative might be 12U NPH + 6U Regular at 1800 and 16U NPH and 8U Regular insulin at MN. Because it can take several days to determine the correct insulin regimen, diabetic patients receiving jejunostomy feedings are cycled as early in their hospital course as possible to avoid delaying discharge for blood sugar management.</p>
<p>Diabetic patients receiving insulin will need careful coordination of tube feeding and insulin administration when they are being transitioned from continuous to nocturnal tube feeds. Patients on continuous tube feeds may receive insulin on a q6 hour schedule, while those receiving nocturnal tube feeds receive insulin at 1800 and MN. When patients on continuous tube feeds are transitioned, the tube feeds are stopped at 10am, to be restarted at 6pm that evening. It is critical that as soon as the tube feeds are stopped at 10am, that the q6 hour insulin as stopped as well.</p>
<p>In either case it is critical that if tube feedings are stopped, standing insulin administration (either q6 hour OR 1800 and MN) be stopped as well. In these cases, sliding scale insulin is generally continued.</p>
<table>
<thead>
<tr class="header">
<th>Day</th>
<th>Time</th>
<th>Tube Feeds</th>
<th>Insulin</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>SUN</td>
<td>MN</td>
<td>60mL/hr</td>
<td>8N+4R</td>
</tr>
<tr class="even">
<td>Mon</td>
<td>6am</td>
<td>60mL/hr</td>
<td>8N+R</td>
</tr>
<tr class="odd">
<td>Mon</td>
<td>Noon</td>
<td>Stop</td>
<td>None</td>
</tr>
<tr class="even">
<td>Mon</td>
<td>6pm</td>
<td>75mL/hr</td>
<td>16N + 8R</td>
</tr>
<tr class="odd">
<td>Mon</td>
<td>MN</td>
<td>75mL/hr</td>
<td>16N+ 8R</td>
</tr>
<tr class="even">
<td>Tues</td>
<td>10am</td>
<td>Stop</td>
<td>None</td>
</tr>
<tr class="odd">
<td>Tues</td>
<td>6pm</td>
<td>75mL/hr</td>
<td>16N+ 8R</td>
</tr>
<tr class="even">
<td>Tues</td>
<td>MN</td>
<td>75mL/hr</td>
<td>16N+ 8R</td>
</tr>
<tr class="odd">
<td>Weds</td>
<td>10am</td>
<td>Stop</td>
<td>None</td>
</tr>
</tbody>
</table>
<p>In this example, the patient was receiving 8N + 4R every 6 hours, so total insulin units per day is (8+4) x 4 = 48units. Because the carbohydrate load of 60mL/hour x 24 is roughly equivalent to 75mL/hour x 16 hours, the total insulin administered is roughly the same. When converted to nocturnal dosing, the patient now received 16+8 = 24 units twice (6pm and MN) = 48U. In practice, it may be wiser to begin by adjusting the dose down a little, to perhaps 14U N and 7U R for the first night.</p>

</div>
</div>



<h3>References</h3>
<div id="refs" class="references csl-bib-body hanging-indent">
<div id="ref-taylor34" class="csl-entry">
Taylor, Fiona G. M., Philip Quirke, Richard J. Heald, Brendan J. Moran, Lennart Blomqvist, Ian R. Swift, David Sebag-Montefiore, Paris Tekkis, Gina Brown, and Magnetic Resonance Imaging in Rectal Cancer European Equivalence Study Study Group. 2014. <span>“Preoperative Magnetic Resonance Imaging Assessment of Circumferential Resection Margin Predicts Disease-Free Survival and Local Recurrence: 5-Year Follow-up Results of the <span>MERCURY</span> Study.”</span> <em>Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology</em> 32 (1): 34–43. <a href="https://doi.org/10.1200/JCO.2012.45.3258">https://doi.org/10.1200/JCO.2012.45.3258</a>.
</div>
</div>
            </section>

          </div>
        </div>
      </div>
<a href="esophagectomy-ward.html" class="navigation navigation-prev " aria-label="Previous page"><i class="fa fa-angle-left"></i></a>
<a href="colorectal-cases---hillsquires.html" class="navigation navigation-next " aria-label="Next page"><i class="fa fa-angle-right"></i></a>
    </div>
  </div>
<script src="libs/gitbook-2.6.7/js/app.min.js"></script>
<script src="libs/gitbook-2.6.7/js/clipboard.min.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-search.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-sharing.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-fontsettings.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-bookdown.js"></script>
<script src="libs/gitbook-2.6.7/js/jquery.highlight.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-clipboard.js"></script>
<script>
gitbook.require(["gitbook"], function(gitbook) {
gitbook.start({
"sharing": {
"github": false,
"facebook": true,
"twitter": true,
"linkedin": false,
"weibo": false,
"instapaper": false,
"vk": false,
"whatsapp": false,
"all": ["facebook", "twitter", "linkedin", "weibo", "instapaper"]
},
"fontsettings": {
"theme": "white",
"family": "sans",
"size": 2
},
"edit": {
"link": "https://github.com/jcsalo/gi_surgonc/edit/main/143-jejunostomy.Rmd",
"text": "Edit"
},
"history": {
"link": null,
"text": null
},
"view": {
"link": null,
"text": null
},
"download": ["gi_surgonc.pdf", "gi_surgonc.epub"],
"search": {
"engine": "fuse",
"options": null
},
"toc": {
"collapse": "section",
"scroll_highlight": true,
"search": true,
"sharing": false
}
});
});
</script>

<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    var src = "true";
    if (src === "" || src === "true") src = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-MML-AM_CHTML";
    if (location.protocol !== "file:")
      if (/^https?:/.test(src))
        src = src.replace(/^https?:/, '');
    script.src = src;
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>
</body>

</html>
